Normalization of glucose levels and sharp reduction in body weight caused by semaglutide has just been found to reduce the incidence of cardiovascular events, even in people without diabetes
A phase 2a, randomized, double-blind, placebo-controlled, three-arm, parallel-group study to assess the efficacy, safety, tolerability and pharmacodynamics of PF-06835919 in patients with non-alcoholic fatty liver disease and type 2 diabetes
It's essential to use caution when considering peptide therapies and to consult with a healthcare professional for personalized advice and to ensure safety
Amanda Staffor, from Kentucky, who is also using Mounjaro, posted a video online where she held up a clump of hair saying that this had fallen out of her hair while she was in the shower